目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global travel vaccines market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global travel vaccines market 2017 - 2021 ($ million)
4.2 Disease Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Disease Type Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Disease Type
6.1 Market segments
Exhibit 30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Disease Type - Market share 2022-2027 (%)
6.2 Comparison by Disease Type
Exhibit 32: Chart on Comparison by Disease Type
Exhibit 33: Data Table on Comparison by Disease Type
6.3 Influenza - Market size and forecast 2022-2027
Exhibit 34: Chart on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Influenza - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Influenza - Year-over-year growth 2022-2027 (%)
6.4 Diphtheria - Market size and forecast 2022-2027
Exhibit 38: Chart on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Diphtheria - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Diphtheria - Year-over-year growth 2022-2027 (%)
6.5 Hepatitis - Market size and forecast 2022-2027
Exhibit 42: Chart on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Hepatitis - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Hepatitis - Year-over-year growth 2022-2027 (%)
6.6 Typhoid and others - Market size and forecast 2022-2027
Exhibit 46: Chart on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Typhoid and others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Typhoid and others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Disease Type
Exhibit 50: Market opportunity by Disease Type ($ million)
Exhibit 51: Data Table on Market opportunity by Disease Type ($ million)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Adult vaccines - Market size and forecast 2022-2027
Exhibit 56: Chart on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Adult vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Adult vaccines - Year-over-year growth 2022-2027 (%)
7.4 Pediatric vaccines - Market size and forecast 2022-2027
Exhibit 60: Chart on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 AstraZeneca Plc
Exhibit 120: AstraZeneca Plc - Overview
Exhibit 121: AstraZeneca Plc - Product / Service
Exhibit 122: AstraZeneca Plc - Key news
Exhibit 123: AstraZeneca Plc - Key offerings
12.5 Bharat Biotech Ltd.
Exhibit 124: Bharat Biotech Ltd. - Overview
Exhibit 125: Bharat Biotech Ltd. - Product / Service
Exhibit 126: Bharat Biotech Ltd. - Key news
Exhibit 127: Bharat Biotech Ltd. - Key offerings
12.6 CSL Ltd.
Exhibit 128: CSL Ltd. - Overview
Exhibit 129: CSL Ltd. - Business segments
Exhibit 130: CSL Ltd. - Key news
Exhibit 131: CSL Ltd. - Key offerings
Exhibit 132: CSL Ltd. - Segment focus
12.7 Dynavax Technologies Corp.
Exhibit 133: Dynavax Technologies Corp. - Overview
Exhibit 134: Dynavax Technologies Corp. - Product / Service
Exhibit 135: Dynavax Technologies Corp. - Key offerings
12.8 GlaxoSmithKline Plc
Exhibit 136: GlaxoSmithKline Plc - Overview
Exhibit 137: GlaxoSmithKline Plc - Business segments
Exhibit 138: GlaxoSmithKline Plc - Key news
Exhibit 139: GlaxoSmithKline Plc - Key offerings
Exhibit 140: GlaxoSmithKline Plc - Segment focus
12.9 KM Biologics Co. Ltd.
Exhibit 141: KM Biologics Co. Ltd. - Overview
Exhibit 142: KM Biologics Co. Ltd. - Product / Service
Exhibit 143: KM Biologics Co. Ltd. - Key offerings
12.10 LG Chem Ltd.
Exhibit 144: LG Chem Ltd. - Overview
Exhibit 145: LG Chem Ltd. - Business segments
Exhibit 146: LG Chem Ltd. - Key news
Exhibit 147: LG Chem Ltd. - Key offerings
Exhibit 148: LG Chem Ltd. - Segment focus
12.11 Merck and Co. Inc.
Exhibit 149: Merck and Co. Inc. - Overview
Exhibit 150: Merck and Co. Inc. - Business segments
Exhibit 151: Merck and Co. Inc. - Key news
Exhibit 152: Merck and Co. Inc. - Key offerings
Exhibit 153: Merck and Co. Inc. - Segment focus
12.12 Novartis AG
Exhibit 154: Novartis AG - Overview
Exhibit 155: Novartis AG - Business segments
Exhibit 156: Novartis AG - Key offerings
Exhibit 157: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 158: Pfizer Inc. - Overview
Exhibit 159: Pfizer Inc. - Product / Service
Exhibit 160: Pfizer Inc. - Key news
Exhibit 161: Pfizer Inc. - Key offerings
12.14 Sanofi SA
Exhibit 162: Sanofi SA - Overview
Exhibit 163: Sanofi SA - Business segments
Exhibit 164: Sanofi SA - Key news
Exhibit 165: Sanofi SA - Key offerings
Exhibit 166: Sanofi SA - Segment focus
12.15 Serum Institute of India Pvt. Ltd.
Exhibit 167: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 168: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 169: Serum Institute of India Pvt. Ltd. - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Valneva SE
Exhibit 174: Valneva SE - Overview
Exhibit 175: Valneva SE - Business segments
Exhibit 176: Valneva SE - Key offerings
Exhibit 177: Valneva SE - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global travel vaccines market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Disease Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Disease Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Disease Type
Exhibits33: Data Table on Comparison by Disease Type
Exhibits34: Chart on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Influenza - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Influenza - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Diphtheria - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Diphtheria - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Hepatitis - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Hepatitis - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Typhoid and others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Typhoid and others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Disease Type ($ million)
Exhibits51: Data Table on Market opportunity by Disease Type ($ million)
Exhibits52: Chart on End-user - Market share 2022-2027 (%)
Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Adult vaccines - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Adult vaccines - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: AstraZeneca Plc - Overview
Exhibits121: AstraZeneca Plc - Product / Service
Exhibits122: AstraZeneca Plc - Key news
Exhibits123: AstraZeneca Plc - Key offerings
Exhibits124: Bharat Biotech Ltd. - Overview
Exhibits125: Bharat Biotech Ltd. - Product / Service
Exhibits126: Bharat Biotech Ltd. - Key news
Exhibits127: Bharat Biotech Ltd. - Key offerings
Exhibits128: CSL Ltd. - Overview
Exhibits129: CSL Ltd. - Business segments
Exhibits130: CSL Ltd. - Key news
Exhibits131: CSL Ltd. - Key offerings
Exhibits132: CSL Ltd. - Segment focus
Exhibits133: Dynavax Technologies Corp. - Overview
Exhibits134: Dynavax Technologies Corp. - Product / Service
Exhibits135: Dynavax Technologies Corp. - Key offerings
Exhibits136: GlaxoSmithKline Plc - Overview
Exhibits137: GlaxoSmithKline Plc - Business segments
Exhibits138: GlaxoSmithKline Plc - Key news
Exhibits139: GlaxoSmithKline Plc - Key offerings
Exhibits140: GlaxoSmithKline Plc - Segment focus
Exhibits141: KM Biologics Co. Ltd. - Overview
Exhibits142: KM Biologics Co. Ltd. - Product / Service
Exhibits143: KM Biologics Co. Ltd. - Key offerings
Exhibits144: LG Chem Ltd. - Overview
Exhibits145: LG Chem Ltd. - Business segments
Exhibits146: LG Chem Ltd. - Key news
Exhibits147: LG Chem Ltd. - Key offerings
Exhibits148: LG Chem Ltd. - Segment focus
Exhibits149: Merck and Co. Inc. - Overview
Exhibits150: Merck and Co. Inc. - Business segments
Exhibits151: Merck and Co. Inc. - Key news
Exhibits152: Merck and Co. Inc. - Key offerings
Exhibits153: Merck and Co. Inc. - Segment focus
Exhibits154: Novartis AG - Overview
Exhibits155: Novartis AG - Business segments
Exhibits156: Novartis AG - Key offerings
Exhibits157: Novartis AG - Segment focus
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: Sanofi SA - Overview
Exhibits163: Sanofi SA - Business segments
Exhibits164: Sanofi SA - Key news
Exhibits165: Sanofi SA - Key offerings
Exhibits166: Sanofi SA - Segment focus
Exhibits167: Serum Institute of India Pvt. Ltd. - Overview
Exhibits168: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits169: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits170: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits171: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits174: Valneva SE - Overview
Exhibits175: Valneva SE - Business segments
Exhibits176: Valneva SE - Key offerings
Exhibits177: Valneva SE - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations